Novel phytochemical compounds for anti-ultraviolet radiation skincare formulations

Overview

This research focuses on discovering novel phytochemical compounds that offer protection against ultraviolet (UV) radiation damage to human skin. The approach targets the three primary mechanisms through which UV radiation harms skin: generation of reactive oxygen species (free radicals), inflammation, and melanin production. By identifying plant-derived compounds with strong antioxidant, anti-inflammatory, and anti-tyrosinase (melanin-inhibiting) properties, the research aims to develop effective skincare formulations that address UV damage at multiple biological levels.

The selected compounds can be formulated into emulsion-based and oil-based skincare products, offering versatile delivery formats for different cosmetic applications. This multi-target approach distinguishes the solution from conventional sunscreens by addressing both UV protection and the downstream biological effects of UV exposure.

Technical specifications

Core technology:

• Identification and validation of phytochemical compounds with three complementary bioactivities: antioxidant (free radical scavenging), anti-inflammatory, and anti-tyrosinase (melanin inhibition)
• Formulation development combining single or multiple compounds matched to their specific bioactivity profiles
• Delivery formats include emulsion-based and oil-based skincare formulations

Validation methods:

• Antioxidant, anti-inflammatory, and anti-tyrosinase effects validated on a curated collection of phytochemicals
• Anti-UV radiation efficacy testing using human keratinocyte cell line (HaCaT)
• Whitening effect assessment using the zebrafish model

Potential applications:

• Skincare products for UV protection
• Whitening and brightening cosmetic formulations
• Anti-aging products addressing oxidative stress and inflammation

Technology readiness level

The research is at an early-to-mid stage of development. Initial validation of the antioxidant, anti-inflammatory, and anti-tyrosinase properties of candidate phytochemicals has been completed. Future validation work will focus on selecting the most promising novel compounds and testing their anti-UV radiation effects at the formulation level using cell-based and organism-based models. Further development would be needed to progress toward commercial product readiness, including clinical validation and formulation optimization.